Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
51.17 USD | -4.44% | -8.45% | -18.26% |
Sales 2024 * | 130M 178M | Sales 2025 * | 289M 394M | Capitalization | 4.34B 5.94B |
---|---|---|---|---|---|
Net income 2024 * | -468M -640M | Net income 2025 * | -430M -588M | EV / Sales 2024 * | 18.9 x |
Net cash position 2024 * | 1.89B 2.58B | Net cash position 2025 * | 1.64B 2.24B | EV / Sales 2025 * | 9.38 x |
P/E ratio 2024 * |
-8.92
x | P/E ratio 2025 * |
-10.4
x | Employees | 407 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.95% |
Latest transcript on CRISPR Therapeutics AG
1 day | -4.44% | ||
1 week | -8.45% | ||
Current month | -3.43% | ||
1 month | -17.12% | ||
3 months | -26.91% | ||
6 months | -3.74% | ||
Current year | -18.26% |
Managers | Title | Age | Since |
---|---|---|---|
Samarth Kulkarni
CEO | Chief Executive Officer | 45 | 15-07-31 |
Raju Prasad
DFI | Director of Finance/CFO | 40 | 23-03-13 |
Stephen Kennedy
CTO | Chief Tech/Sci/R&D Officer | 67 | 19-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Doug Treco Treco
BRD | Director/Board Member | 66 | 20-06-10 |
Simeon George
BRD | Director/Board Member | 46 | 15-04-28 |
Ali Behbahani
BRD | Director/Board Member | 47 | 15-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
10.82% | 0 M€ | +12.39% | - | |
8.55% | 2 M€ | -25.75% | ||
4.84% | 0 M€ | 0.00% | - | |
4.53% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 51.17 | -4.44% | 1,633,771 |
24-05-09 | 53.55 | +0.49% | 1,701,154 |
24-05-08 | 53.29 | -4.03% | 1,552,923 |
24-05-07 | 55.53 | -2.68% | 1,377,180 |
24-05-06 | 57.06 | +2.09% | 1,453,162 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.26% | 4.34B | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- CRSP Stock